PDF(Pubmed)
Abstract：
Prostate cancer (PCa) is a prevalent male malignancy that originates in the epithelial cells of the prostate. In terms of incidence and mortality of malignant tumors in men, PCa ranks second and fifth globally and first and third among men in Europe and the United States, respectively. These figures have gradually increased in recent years. The primary modalities used to diagnose PCa include prostate-specific antigen (PSA), multiparametric magnetic resonance imaging (mpMRI), and prostate puncture biopsy. Among these techniques, prostate puncture biopsy is considered the gold standard for the diagnosis of PCa; however, this method carries the potential for missed diagnoses. The preoperative evaluation of the patient in this study suggested advanced PCa. However, the initial prostate puncture biopsy was inconsistent with the preoperative diagnosis, and instead of waiting for a repeat puncture of the prostate primary, we performed a biopsy of the rib metastasis, which was later diagnosed as advanced PCa.
摘要：
前列腺癌（PCa）是一种普遍存在的男性恶性肿瘤，起源于前列腺的上皮细胞。就男性恶性肿瘤的发病率和死亡率而言，PCa在全球排名第二和第五，在欧洲和美国的男性中排名第一和第三，分别。这些数字近年来逐渐增加。用于诊断PCa的主要方式包括前列腺特异性抗原（PSA），多参数磁共振成像（MPMRI），前列腺穿刺活检.在这些技术中,前列腺穿刺活检被认为是诊断PCa的金标准;然而,这种方法有可能导致漏诊.在这项研究中，对患者的术前评估提示晚期PCa。然而,最初的前列腺穿刺活检与术前诊断不一致，而不是等待前列腺的重复穿刺，我们做了肋骨转移活检,后来被诊断为晚期PCa。
